TWSE
Every company in the roster listed on TWSE.
Every company in the roster listed on TWSE.
3 of 3 companies
| Company | Pipeline | Most advanced | Next readout | Market cap | Cash & inv. | Runway | R&D / yr |
|---|---|---|---|---|---|---|---|
PharmaEssentia Corporation6446 · TWSE | 1 asset: 1 approved | Approved assets only | 18 Nov 2027Ropeginterferon alfa-2b (Besremi) · Phase 3 | — | — | — | — |
Polaris Group6550 · TWSE | 1 asset: 1 Ph 3 | PegargiminasePhase 3 · Hepatocellular CarcinomaWeak signal | Jan 2027Pegargiminase · Phase 1 | — | — | — | — |
Upsher-Smith Laboratories, LLC6472 · TWSE | 2 assets: 2 approved | Approved assets only | None on record | — | — | — | — |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov). Cash shows its balance-sheet month; runway shows a month only when it comes from an earlier report.